Published in Ann N Y Acad Sci on April 01, 2000
Detection of cancer DNA in plasma of patients with early-stage breast cancer. Clin Cancer Res (2014) 3.50
Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care (2006) 1.78
Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res (2007) 1.62
Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients. Cancer Res (2006) 1.32
Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls. J Mol Diagn (2009) 1.19
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients. Clin Cancer Res (2015) 1.18
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. Hugo J (2011) 1.13
Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping. J Exp Clin Cancer Res (2013) 1.10
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients. Br J Cancer (2009) 1.09
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. Cancer (2010) 1.07
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology. J Mol Diagn (2015) 1.04
The awakening of an advanced malignant cancer: an insult to the mitochondrial genome. Biochim Biophys Acta (2011) 1.02
Blood and tissue biomarkers in prostate cancer: state of the art. Urol Clin North Am (2010) 1.02
Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer (2001) 0.97
Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease. Eur J Med Res (2010) 0.96
Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer. EBioMedicine (2016) 0.95
Non-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women's Healthcare Practitioners. Curr Genet Med Rep (2013) 0.93
Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology. Onco Targets Ther (2013) 0.92
Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease. Br J Cancer (2015) 0.92
A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer. Breast Cancer Res (2007) 0.92
The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC. Br J Cancer (2013) 0.91
Detection of IL28B SNP DNA from buccal epithelial cells, small amounts of serum, and dried blood spots. PLoS One (2012) 0.89
Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance. Genome Biol (2014) 0.86
Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer. Oncotarget (2016) 0.86
Cell-free circulating tumor DNA in cancer. Chin J Cancer (2016) 0.85
Detection of hypermethylated vimentin in urine of patients with colorectal cancer. J Mol Diagn (2012) 0.84
Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA. Eur J Hum Genet (2016) 0.84
A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine. J Mol Diagn (2011) 0.83
New blood markers detection technology: A leap in the diagnosis of gastric cancer. World J Gastroenterol (2016) 0.82
Detection of epidermal growth factor receptor mutation in plasma as a biomarker in Chinese patients with early-stage non-small cell lung cancer. Onco Targets Ther (2015) 0.81
Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients. J Cancer Res Clin Oncol (2010) 0.80
Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection. Front Genet (2014) 0.80
[Molecular diagnostics of non-small cell lung cancer: New markers and technologies]. Pathologe (2015) 0.80
Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection. Diagn Pathol (2015) 0.79
Disease-specific motifs can be identified in circulating nucleic acids from live elk and cattle infected with transmissible spongiform encephalopathies. Nucleic Acids Res (2008) 0.79
Plasma DNA restoration for PCR applications. J Clin Pathol (2007) 0.78
Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer. Oncotarget (2016) 0.78
The liquid biopsy in lung cancer. Genes Cancer (2016) 0.76
Cell free fetal DNA testing in maternal blood of Romanian pregnant women. Iran J Reprod Med (2015) 0.76
Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index. PLoS One (2017) 0.75
Lack of reliability of nanotechnology in the of free plasma DNA in samples of patients with prostate cancer. Int Arch Med (2013) 0.75
Clinical Utility of Non-Invasive Prenatal Screening from Maternal Blood. Maedica (Buchar) (2015) 0.75
Prognostic biomarkers in ovarian cancer. Cancer Biomark (2011) 0.75
Very Short Mitochondrial DNA Fragments and Heteroplasmy in Human Plasma. Sci Rep (2016) 0.75
A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours. Clin Epigenetics (2017) 0.75
Clinical relevance of cell-free DNA in gastrointestinal tract malignancy. Oncotarget (2016) 0.75
Quantification of cell-free DNA for evaluating genotoxic damage from occupational exposure to car paints. J Occup Med Toxicol (2016) 0.75
Multianalyte tests for the early detection of cancer: speedbumps and barriers. Biomark Insights (2007) 0.75
Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma. Transl Oncol (2012) 0.75
Cell-Free DNA in Oncology: Gearing up for Clinic. Ann Lab Med (2018) 0.75
Preconditioning with intravenous colitic cell-free DNA prevents DSS-colitis by altering TLR9-associated gene expression profile. Dig Dis Sci (2014) 0.75
[Liquid biopsy analysis using cell-free DNA (cfDNA) : Opportunities and limitations]. Pathologe (2015) 0.75
The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol (1996) 5.41
PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell (1998) 4.82
Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol (1997) 4.28
Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother (2004) 3.87
Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med (1996) 2.95
A conserved negative regulatory region in alphaPAK: inhibition of PAK kinases reveals their morphological roles downstream of Cdc42 and Rac1. Mol Cell Biol (1998) 2.92
Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med (1996) 2.85
Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (2000) 2.79
Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev (1999) 2.21
About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta (2001) 2.18
Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J Cell Biol (1998) 2.14
Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization. Mol Cell Biol (1998) 2.08
Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology (1989) 2.03
Multiple origins of cultivated grapevine (Vitis vinifera L. ssp. sativa) based on chloroplast DNA polymorphisms. Mol Ecol (2006) 2.02
Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog (1991) 1.87
The surgical treatment of constrictive fibrous endocarditis. Ann Surg (1976) 1.81
BRK/Sik expression in the gastrointestinal tract and in colon tumors. Clin Cancer Res (1999) 1.59
Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability. Mol Cell Biol (2000) 1.58
Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol (1994) 1.55
Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res (2000) 1.54
Goitre and hypothyroidism in the newborn after cutaneous absorption of iodine. Arch Dis Child (1978) 1.53
Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system. Cancer Res (1975) 1.51
[Trisomy for the distal part of the short arm of the number 3 chromosome in 3 siblings. First example of chromosomal insertion: INS(7;3)(q 31;p 21 p 26)]. Ann Genet (1972) 1.50
Firearms injury prevention and gun control in Canada. CMAJ (1996) 1.46
RhoA-binding kinase alpha translocation is facilitated by the collapse of the vimentin intermediate filament network. Mol Cell Biol (1998) 1.46
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. J Infect Dis (1999) 1.45
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol (2008) 1.42
Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol (1987) 1.37
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res (1998) 1.36
Surgical treatment of constrictive fibrous endocarditis. J Thorac Cardiovasc Surg (1981) 1.32
K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology (1997) 1.29
Agrobacterium tumefaciens ribonucleic acid synthesis in tomato cells and crown gall induction. J Bacteriol (1971) 1.19
Bacterial nucleic acid synthesis in plants following bacterial contact. Mol Gen Genet (1971) 1.18
Natural release of nucleic acids from bacteria into plant cells. Nature (1970) 1.16
Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: evidence for a preferential release from viable cells? Ann N Y Acad Sci (2001) 1.15
Self-injurious behavior prevalence and relationships to environmental events. Monogr Am Assoc Ment Defic (1982) 1.14
Non-invasive diagnosis of mitral regurgitation by Doppler echocardiography. Br Heart J (1981) 1.14
Circulating nucleic acids in plasma or serum. Clin Chim Acta (2001) 1.13
DNA replication in Solanum lycopersicum esc. after absorption of bacterial DNA. Curr Mod Biol (1967) 1.11
Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res (1999) 1.07
Experimental Blastocystis hominis infection in laboratory mice. Parasitol Res (1997) 1.07
Bacterial RNA synthesis in animal cells following bacterial contact. FEBS Lett (1971) 1.07
Aqueous dynamic and histological findings after deep sclerectomy with collagen implant in an animal model. Br J Ophthalmol (2003) 1.07
Non-invasive quantification of aortic regurgitation by Doppler echocardiography. Br Heart J (1983) 1.07
[The weight and size of newborn infants at birth]. Rev Fr Gynecol Obstet (1971) 1.06
Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res (1998) 1.06
Pulsed doppler echocardiographic study of mitral stenosis. Circulation (1980) 1.05
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance. Ann Oncol (2000) 1.04
Linker mutation scanning of the genes encoding the adenovirus type 5 terminal protein precursor and DNA polymerase. Virology (1991) 1.02
The biomimetic immunoassay based on molecularly imprinted polymer: a comprehensive review of recent progress and future prospects. J Food Sci (2011) 1.01
[Cerebral gigantism in children: determination of growth hormone in the plasma]. Arch Fr Pediatr (1968) 1.01
Prognostic factors of sacral chordoma after surgical therapy: a study of 36 patients. Spinal Cord (2009) 0.98
[Hockey injuries: consultations in a hospital center in Quebec]. Can J Public Health (1996) 0.98
[Partial 7 q trisomy. One or 2 syndromes? Apropos of a new case]. Ann Genet (1976) 0.97
Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res (1978) 0.97
Evaluation of diagnostic criteria for atopic dermatitis: validity of the criteria of Williams et al. in a hospital-based setting. Br J Dermatol (2001) 0.95
[Dwarfism caused by sporadic and idiopathic pituitary insufficiency. Study of a series of 31 cases]. Arch Fr Pediatr (1972) 0.94
Combined chemo- and hormonal therapy in advanced breast cancer. Cancer (1977) 0.93
Nucleic acids spontaneously released by living frog auricles. Biochem J (1972) 0.92
Circulating nucleic acids in higher organisms. Int Rev Cytol (1977) 0.92
[Hemodynamic effects of intravenous injections of amiodarone chlorhydrate in normal subjects and coronary patients]. Arch Mal Coeur Vaiss (1976) 0.91
[Disorders of rhythm and auriculo-ventricular conduction in recent myocardial infarct. Anatomical considerations]. Arch Mal Coeur Vaiss (1967) 0.91
Translocation of DNA of bacterial origin in Lycopersicum esculentum by ultracentrifugation in caesium chloride gradient. Nature (1967) 0.91
[Chimera 46,XX-69,XXY]. Ann Genet (1967) 0.90
Plasma DNA K-ras mutations in patients with gastrointestinal malignancies. Ann N Y Acad Sci (2000) 0.90